A2Z CUST2MATE SOLUTIONS CORP.
No SEC Form 4 filings for $AZ in the last 30 days.
See all $AZ insider activity →According to A2Z Cust2Mate Solutions Corp. (AZ), Q2 2026 revenue rose 78% sequentially, driven by Smart Cart deliveries and new customer wins. Gross margin improved to 42.6%. The company secured a $30M credit line and guided for 10,000 carts delivered by year-end and at least $25M in H2 revenue, with retail media ramping.
A2Z Cust2Mate Solutions Corp. (AZ) reported Q2 adjusted EPS loss of $0.16, matching the Zacks Consensus Estimate, versus a $0.31 loss a year earlier. Revenue rose to $5.9M for the quarter ended June 2026, beating consensus by 73.65% and up from $1.16M a year ago. Consensus for next quarter is -$0.09 EPS on $8.7M revenue.
According to A2Z Cust2Mate Solutions Corp.’s Aug. 12, 2026 SEC 6-K, revenue for the six months ended June 30, 2026 rose to $9.2M, driven by smart cart growth. Net loss narrowed to $15.6M. The company cited major new contracts and a $30.9M credit facility, but said it still relies on external financing and is addressing internal control weaknesses.
Over the past 7 days, alphai's AI scored 5 news stories mentioning AZ (A2Z CUST2MATE SOLUTIONS CORP.). Coverage has skewed bullish: 3 bullish, 2 neutral, and 0 bearish.
Recent AZ coverage spans earnings, mergers & acquisitions and market movers.
The article discloses a fresh Q2 performance update plus forward delivery and revenue guidance, which can reprice near-term expectations.
The print is a mixed fundamental signal: revenue upside versus continued EPS losses, with near-term direction likely driven by management commentary and estimate revisions.
Growth is improving but the company still shows heavy loss-making and ongoing reliance on external financing, plus internal control weaknesses.
The quarter shows sharp scale-up in deliveries and margin expansion, supported by new manufacturing capacity and fresh financing, with explicit H2 revenue expectations.
The earnings beat on both EPS and revenue is the only company-specific catalyst in the text, supporting a near-term sentiment lift but with limited detail on guidance or margins.
alphai scores every news story that mentions AZ with an AI model for sentiment and relevance, and aggregates insider trades from A2Z CUST2MATE SOLUTIONS CORP.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
According to A2Z Cust2Mate Solutions Corp. (AZ), Q2 2026 revenue rose 78% sequentially, driven by Smart Cart deliveries and new customer wins. Gross margin improved to 42.6%. The company secured a $30M credit line and guided for 10,000 carts delivered by year-end and at least $25M in H2 revenue, with retail media ramping.
1 min readA2Z Cust2Mate Solutions Corp. (AZ) reported Q2 adjusted EPS loss of $0.16, matching the Zacks Consensus Estimate, versus a $0.31 loss a year earlier. Revenue rose to $5.9M for the quarter ended June 2026, beating consensus by 73.65% and up from $1.16M a year ago. Consensus for next quarter is -$0.09 EPS on $8.7M revenue.
5 min readAccording to A2Z Cust2Mate Solutions Corp.’s Aug. 12, 2026 SEC 6-K, revenue for the six months ended June 30, 2026 rose to $9.2M, driven by smart cart growth. Net loss narrowed to $15.6M. The company cited major new contracts and a $30.9M credit facility, but said it still relies on external financing and is addressing internal control weaknesses.
1 min readA2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) reported Q2 2026 revenue of $5.9 million, up from $1.2 million, with Smart Cart revenue of $4.41 million. Gross profit rose to $2.5 million and gross margin to 42.6%. Net loss was $7.3 million. The company cited a $30 million credit line with Bank Leumi and expects $25 million in H2 smart cart revenue.
6 min readA2Z Smart Technologies ($AZ) reported Q2 2026 results on Aug. 12. The company posted EPS of -$0.16, above the -$0.25 estimate, and revenue of $5.9 million, above the $5.24 million estimate. The article also cites institutional investors adding and reducing $AZ positions in recent quarters.
2 min readAllianz Global Investors agreed to acquire UOB Asset Management for S$555m (US$432.7m), covering UOBAM operations in eight Asian markets. UOB and AGI will also form a distribution partnership. UOB expects a pre-tax gain of about S$330m and a CET ratio lift of 14 bps, subject to regulatory approval, with closing in 2027.
3 min readUOB will sell its asset management arm, UOB Asset Management, to Allianz Global Investors for S$555 million, including excess cash. UOB expects a pre-tax gain of about S$330 million and a CET1 ratio increase of ~14 bps. The sold stake’s net asset value was S$223 million (unaudited pro forma). Deal to close in 2027, subject to approvals.
4 min readPathos AI said it licensed Alphamab’s bispecific ADC JSKN016 for solid tumors outside Greater China in a deal worth up to $2.2 billion, including $125 million upfront, up to $2.09 billion in milestones and royalties. JSKN016 targets TROP2 and HER3 and is in Phase 3 for TNBC. Pathos also partnered with AstraZeneca on AZD4241, an ER-targeting PROTAC in preclinical testing for HR-positive, HER2-negative breast cancer.
3 min readFTSE 100 is down 14 points to 10,854, with AstraZeneca falling on reports of Bristol-Myers Squibb merger talks. Shell agreed to sell its European onshore renewables portfolio to TotalEnergies for an undisclosed sum. In the US, Microsoft, Amazon and Alphabet helped lift Wall Street. UK manufacturing PMI came in at 51.9 in July.
7 min readFTSE 100 trades around 10,866-10,888, with gains in housebuilders and airlines as gilt yields and oil fall. AstraZeneca shares drop on reports of Bristol-Myers merger talks. Shell agreed to sell its European onshore renewables unit to TotalEnergies, including ~500MW capacity and a 3.5GW pipeline. UK manufacturing PMI was 51.9 (July).
7 min read
